ASH 2017: Atlanta Professor Michael Hallek on MRD Negativity in CLL
Genetic tests can be important tools after an initial cancer diagnosis, helping doctors ensure the absolute best treatment available for a specific patient with a specific kind of cancer.
To follow-up on the Facebook chat I had at the ASH meeting last December, I will be hosting another Facebook Live Interactive workshop on the importance of genetic testing before treatment in CLL. I will be broadcasting from the 17th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) being held in New York City.
Join me, ask questions and cheer me along at 3:45 PM ET on this Saturday, May 13th.
Your link to join is https://www.facebook.com/CLLsociety/
I look forward to your questions and to hearing your thoughts.
Stay strong.
We are all in this together.
Brian Koffman, MD 5-12-17
Related posts